Your browser doesn't support javascript.
loading
Towards remote monitoring in pediatric care and clinical trials-Tolerability, repeatability and reference values of candidate digital endpoints derived from physical activity, heart rate and sleep in healthy children.
Kruizinga, M D; Heide, N van der; Moll, A; Zhuparris, A; Yavuz, Y; Kam, M L de; Stuurman, F E; Cohen, A F; Driessen, G J A.
Affiliation
  • Kruizinga MD; Centre for Human Drug Research, Leiden, The Netherlands.
  • Heide NV; Juliana Children's Hospital, HAGA Teaching Hospital, The Hague, The Netherlands.
  • Moll A; Leiden University Medical Centre, Leiden, The Netherlands.
  • Zhuparris A; Centre for Human Drug Research, Leiden, The Netherlands.
  • Yavuz Y; Juliana Children's Hospital, HAGA Teaching Hospital, The Hague, The Netherlands.
  • Kam ML; Centre for Human Drug Research, Leiden, The Netherlands.
  • Stuurman FE; Juliana Children's Hospital, HAGA Teaching Hospital, The Hague, The Netherlands.
  • Cohen AF; Centre for Human Drug Research, Leiden, The Netherlands.
  • Driessen GJA; Centre for Human Drug Research, Leiden, The Netherlands.
PLoS One ; 16(1): e0244877, 2021.
Article in En | MEDLINE | ID: mdl-33411722
ABSTRACT

BACKGROUND:

Digital devices and wearables allow for the measurement of a wide range of health-related parameters in a non-invasive manner, which may be particularly valuable in pediatrics. Incorporation of such parameters in clinical trials or care as digital endpoint could reduce the burden for children and their parents but requires clinical validation in the target population. This study aims to determine the tolerability, repeatability, and reference values of novel digital endpoints in healthy children.

METHODS:

Apparently healthy children (n = 175, 46% male) aged 2-16 were included. Subjects were monitored for 21 days using a home-monitoring platform with several devices (smartwatch, spirometer, thermometer, blood pressure monitor, scales). Endpoints were analyzed with a mixed effects model, assessing variables that explained within- and between-subject variability. Endpoints based on physical activity, heart rate, and sleep-related parameters were included in the analysis. For physical-activity-related endpoints, a sample size needed to detect a 15% increase was calculated.

FINDINGS:

Median compliance was 94%. Variability in each physical activity-related candidate endpoint was explained by age, sex, watch wear time, rain duration per day, average ambient temperature, and population density of the city of residence. Estimated sample sizes for candidate endpoints ranged from 33-110 per group. Daytime heart rate, nocturnal heart rate and sleep duration decreased as a function of age and were comparable to reference values published in the literature.

CONCLUSIONS:

Wearable- and portable devices are tolerable for pediatric subjects. The raw data, models and reference values presented here can be used to guide further validation and, in the future, clinical trial designs involving the included measures.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Monitoring, Physiologic Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Monitoring, Physiologic Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Type: Article Affiliation country: Netherlands